000 01330 a2200349 4500
005 20250514021450.0
264 0 _c20020125
008 200201s 0 0 eng d
022 _a0385-2407
024 7 _a10.1111/j.1346-8138.2001.tb00057.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTakamori, K
245 0 0 _aRecent advances in the treatment of autoimmune bullous diseases.
_h[electronic resource]
260 _bThe Journal of dermatology
_cNov 2001
300 _a654-7 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnti-Inflammatory Agents, Non-Steroidal
_xadministration & dosage
650 0 4 _aCombined Modality Therapy
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunoglobulins, Intravenous
_xadministration & dosage
650 0 4 _aImmunosuppressive Agents
_xadministration & dosage
650 0 4 _aMale
650 0 4 _aMycophenolic Acid
_xadministration & dosage
650 0 4 _aPlasmapheresis
_xmethods
650 0 4 _aPrognosis
650 0 4 _aSkin Diseases, Vesiculobullous
_xdiagnosis
773 0 _tThe Journal of dermatology
_gvol. 28
_gno. 11
_gp. 654-7
856 4 0 _uhttps://doi.org/10.1111/j.1346-8138.2001.tb00057.x
_zAvailable from publisher's website
999 _c11682806
_d11682806